Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: Functional results in 54 patients

Acta Ophthalmologica

Volumn 87, Issue 2, 2009, Pages 183-187

  Frimpong Boateng, Adjoa ^a   Bunse, Arnd ^a   Rüfer, Florian ^a   Roider, Johann ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Age related macular degeneration; Anti VEGF therapy; Photodynamic therapy; Triamcinolone acetonide

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CATARACT; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPYON; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; CHOROIDAL NEOVASCULARIZATION; DRUG SYNERGISM; FEMALE; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 61449112923     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01213.x     Document Type: Article

References (22)

1. Antoszyk AN, Gottlieb JL, Machemer R Hatchell DL (1993 The effects of intravitreal triamcinolone acetonide on experimental preretinal neovascularization. Graefes Arch Clin Exp Ophthalmol 231 : 34 40.
2. Augustin AJ Schmidt-Erfurth U (2006 Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology 113 : 14 22.
3. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB III. Miller M (2003 Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110 : 681 686.
4. Brown DM, Shapiro H, Schneider S the ANCHOR Study Group (2006 Subgroup analysis of first-year results of ANCHOR: a phase III, double-masked, randomized comparison of ranibizumab and verteporfin photodynamic therapy for predominantly classic choroidal neovascularization related to age-related macular degeneration. Presented at the Association for Research in Vision and Ophthalmology, 30 April - 4 May 2006, Fort Lauderdale, Florida. Abstract 2963.
5. Chan WM, Lai TY, Wong AL et al. (2006 Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal neovascularization in age-related macular degeneration; a comparative study. Br J Ophthalmol 90 : 337 341.
6. D'Amico DJ, Masonson HN, Patel M, Adamis AP, Cunningham ET Jr., Guyer DR Katz B (2006 VEGF Inhibition Study in Ocular Neovascularization (VISION) Clinical Trial Group; pegaptanib sodium for neovascular age-related macular degeneration: 2-year safety results of the two prospective, multicentre, controlled clinical trials. Ophthalmology 113 : 992 1001.
7. Folkman J Ingber DE (1987 Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 206 : 374 383.
8. Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M, Guyer DR the VEGF Inhibition Study in Ocular Neovascularization (VISION) Clinical Trial Group (2004 Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 : 2805 2816.
9. TM) for minimally classic or occult neovascular age-related macular degeneration: 2-year efficacy results of the MARINA Study. Presented at the Association for Research in Vision and Ophthalmology, 30 April - 4 May 2006, Fort Lauderdale, Florida. Abstract 2959.
10. Jonas JB (2005 Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. [Review Acta Ophthalmol Scand 83 : 645 663.
11. Jonas JB, Kreissig I, Söfker A Degenring RF (2003a Intravitreal injection of triamcinolone acetonide for diabetic macular oedema. Arch Ophthalmol 121 : 57 615.
12. Jonas JB, Kreissig I Degenring RF (2003b Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 121 : 1663 1664.
13. Krebs I, Binder S Stolba U (2005 A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006 244 : 863 7.
14. Kyto JP, Angerman S, Lumiste E, Paloheimo M Summanen PA (2005 Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: case report with 22 weeks follow-up. Acta Ophthalmol Scand 83 : 605 608.
15. Nicolo M, Ghiglione D, Lai S, Nasciuti F, Cicinelli S Calabria G (2006 Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Retina 26 : 58 64.
16. Rechtman E, Danis RP, Pratt LM Harris A (2004 Intravitreal triamcinolone with photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Br J Ophthalmol 88 : 344 347.
17. Schmidt-Erfurth U, Schlötzer-Schrehard U et al. (2003 Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44 : 4473 4480.
18. Smithen LM Spaide R (2004 Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal teleangiectasis. Am J Ophthalmol 138 : 884 885.
19. Spaide RF, Sorenson J Maranan L (2005 Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112 : 301 304.
20. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of two randomized clinical trials. TAP Report 2. Arch Ophthalmol 119 : 198 207.
21. Tatar O, Adam A, Shinoda K et al. (2006 Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy. Am J Ophthalmol 142 : 95 104.
22. Verteporfin in Photodynamic Therapy (VIP) Study Group (2001 Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. Verteporfin in Photodynamic Therapy Report 2. Ophthalmology 131 : 541 560.